Recently, the high LC3 expression, by immunohistochemistry analysis, both in the tumour and non-tumour liver was significantly associated with lower HCC recurrence in patients who underwent curative hepatectomy for HCC [60]. Here, MAP1LC3A is linked to neoplasm.